Vachellia farnesiana Pods or a Polyphenolic Extract Derived from Them Exert Immunomodulatory, Metabolic, Renoprotective, and Prebiotic Effects in Mice Fed a High-Fat Diet

Abstract

Obesity causes systemic inflammation, hepatic and renal damage, as well as gut microbiota dysbiosis. Alternative vegetable sources rich in polyphenols are known to prevent or delay the progression of metabolic abnormalities during obesity. Vachellia farnesiana (VF) is a potent source of polyphenols with antioxidant and anti-inflammatory activities with potential anti-obesity effects. We performed an in vivo preventive or an interventional experimental study in mice and in vitro experiments with different cell types. In the preventive study, male C57BL/6 mice were fed with a Control diet, a high-fat diet, or a high-fat diet containing either 0.1% methyl gallate, 10% powdered VFP, or 0.5%, 1%, or 2% of a polyphenolic extract (PE) derived from VFP (Vachellia farnesiana pods) for 14 weeks. In the intervention study, two groups of mice were fed for 14 weeks with a high-fat diet and then one switched to a high-fat diet with 10% powdered VFP for ten additional weeks. In the in vitro studies, we evaluated the effect of a VFPE (Vachellia farnesiana polyphenolic extract) on glucose-stimulated insulin secretion in INS-1E cells or of naringenin or methyl gallate on mitochondrial activity in primary hepatocytes and C2C12 myotubes. VFP or a VFPE increased whole-body energy expenditure and mitochondrial activity in skeletal muscle; prevented insulin resistance, hepatic steatosis, and kidney damage; exerted immunomodulatory effects; and reshaped fecal gut microbiota composition in mice fed a high-fat diet. VFPE decreased insulin secretion in INS-1E cells, and its isolated compounds naringenin and methyl gallate increased mitochondrial activity in primary hepatocytes and C2C12 myotubes. In conclusion VFP or a VFPE prevented systemic inflammation, insulin resistance, and hepatic and renal damage in mice fed a high-fat diet associated with increased energy expenditure, improved mitochondrial function, and reduction in insulin secretion.

Rhythm and ROS: Hepatic Chronotherapeutic Features of Grape Seed Proanthocyanidin Extract Treatment in Cafeteria Diet-Fed Rats

“…[ 51 ]. In this context, AOX therapy using natural compounds in the diet, especially phenolic compounds, has been proven to be an effective and safe approach to addressing the consequences of ROS in obesity [ 52 , 53 , 54 , 55 ]. More concisely, the AOX activities of these compounds depend not only on their scavenger activity but also on their ability to prevent the activation of transcriptional factors such as NF-κB (nuclear factor κ-light-chain-enhancer of activated B cells) and reduce the expression of target genes, including those involved in inflammation [ 56 , 57 , 58 , 59 , 60 ].…”

Gut Microbiota Interventions to Retain Residual Kidney Function

“…Polyphenols have anti-inflammatory and antioxidant properties that can be renoprotective and affect gut microbiota since they can act as a prebiotic [ 114 ]. Polyphenols usually have poor intestinal absorption, but after the biotransformation by the microbiota, they are hydrolysed and absorbed.…”

A Novel Plant-Based Nutraceutical Combined with Exercise Can Revert Oxidative Status in Plasma and Liver in a Diet-Induced-Obesity Animal Model

“…The gut microbiota is also accepted as one of the main environmental factors involved in the development of obesity [ 10 ]. Moreover, the high capacity to absorb energy by intestinal microbiota is essential in regulating fat accumulation, energy homeostasis, and mucosal barrier integrity.…”